NCT01151930

Brief Summary

The primary objective is to characterize the safety profile of long-term exposure to SCB01A when administered to cancer subjects with advanced solid tumors. Furthermore, the efficacy profile will also be explored in this study.

Trial Health

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2010

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 29, 2010

Completed
Last Updated

November 17, 2020

Status Verified

October 1, 2017

First QC Date

June 23, 2010

Last Update Submit

November 12, 2020

Conditions

Keywords

Advanced solid tumor failed with standard therapy

Interventions

SCB01ADRUG

This is a companion study to the protocol SCB01A-01 intended to provide long-term continued administration to subjects that completed Protocol SCB01A-01 on a compassionate basis. It is an open-label, single-arm study of SCB01A in subjects who have completed 2 cycles of treatment under the SCB01A-01 protocol.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects who completed protocol SCB01A-01 and exhibited a favorable response or had no clinical evidence of disease progression (i.e. stable disease, partial response or complete response).

You may not qualify if:

  • Study participants meeting any of the following criteria will be excluded from enrollment:
  • Unwilling or unable to provide informed consent.
  • Unwilling or unable to comply with the requirements of the protocol.
  • Has unresolved toxicities from previous SCB01A-01 protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Shiah HS, Chiang NJ, Lin CC, Yen CJ, Tsai HJ, Wu SY, Su WC, Chang KY, Wang CC, Chang JY, Chen LT. Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors. Oncologist. 2021 Apr;26(4):e567-e579. doi: 10.1002/onco.13612. Epub 2020 Dec 18.

Study Design

Study Type
expanded access
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2010

First Posted

June 29, 2010

Last Updated

November 17, 2020

Record last verified: 2017-10